Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,786 public trials 2,167 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

NCT05514548

Conditions
Autoimmune Diseases, Diabetes Complications, Diabetes Mellitus, +15 more
Locations
  • National Institute of Clinical Research, Inc. Garden Grove, California, United States
  • National Institute of Clinical Research, Inc - Pomona Pomona, California, United States
  • Central Coast Nephrology Salinas, California, United States
  • North American Research Institute San Dimas, California, United States
View all 72 locations
View Trial Details
Completed

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

NCT04825834

Conditions
Bladder Cancer, Colonic Diseases, Colorectal Cancer, +48 more
Locations
  • Central Alabama Research Homewood, Alabama, United States
  • Phoenix Medical Group Peoria, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Pulmonary Associates of Burlingame Burlingame, California, United States
View all 57 locations
View Trial Details
Completed

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

NCT03685448

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations
  • Border Medical Oncology Research Unit / The Border Cancer Hospital Albury, New South Wales, Australia
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • St George Hospital Kogarah, New South Wales, Australia
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
View Trial Details
Completed

Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery.

NCT03709264

Conditions
Acute Kidney Injury, Cardiac Surgery, Female Urogenital Diseases, +6 more
Locations
  • University Hospital Dubrava Dubrava, Croatia
  • Magdalena Clinic for Cardiovascular Diseases Zagreb, Croatia
  • Ospedale San Carlo Potenza, Basilicate, Italy
  • Ospedale Mater Domini Catanzaro, Calabria, Italy
View all 22 locations
View Trial Details
Completed

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

NCT05585034

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +58 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View Trial Details

Related conditions